Cowen And Company, LLC Rigel Pharmaceuticals Inc Call Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $23,600 - $35,700	-10,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $50,750 - $65,250	-14,500 Reduced 59.18%	10,000 $2,000
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $166,551 - $244,706	-53,900 Reduced 68.75%	24,500 $14,000
Q1 2021 May 04, 2021	BUY	$3.35 - $4.93 $62,645 - $92,191	18,700 Added 31.32%	78,400 $42,000
Q4 2020 Feb 08, 2021	BUY	$2.35 - $3.74 $52,170 - $83,028	22,200 Added 59.2%	59,700 $43,000
Q3 2020 Nov 03, 2020	BUY	$1.78 - $4.13 $66,750 - $154,875	37,500 New	37,500 $19,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.